$10.95 0.00 (0%)
2/10/2012 4:00 PM

Micromet, Inc. (NASDAQ:MITI)

CAPS Rating: 2 out of 5

Results 1 - 20 of 25 : 1 2 Next »

Recs

0
Member Avatar studiorite (34.03) Submitted: 7/25/2011 10:13:47 AM : Outperform Start Price: $5.94 MITI Score: +84.07

give it a shot

Recs

0
Member Avatar idvst8 (< 20) Submitted: 7/22/2011 2:07:53 PM : Outperform Start Price: $6.12 MITI Score: +79.09

MITI - Offer huge upside in the BioTech sector. I firmly believe this company will get bought out in the next 12-24 months.

Recs

0
Member Avatar TROYHE (< 20) Submitted: 7/7/2011 11:35:39 AM : Outperform Start Price: $5.98 MITI Score: +83.64

I like the research MITI is doing

Recs

0
Member Avatar shanelopez (< 20) Submitted: 6/30/2011 9:51:54 PM : Outperform Start Price: $5.77 MITI Score: +88.06

Market sentiment on selected stocks

Recs

0
Member Avatar EruditeInvestor (33.16) Submitted: 12/28/2010 11:22:25 AM : Outperform Start Price: $8.36 MITI Score: +24.03

While a highly speculative pick, a new anti-cancer drug in Phase II trials appears to be very promising.

Recs

0
Member Avatar clancykid (< 20) Submitted: 12/4/2010 11:09:20 AM : Underperform Start Price: $7.73 MITI Score: -32.09

From the board chair to the other principals, they are all selling shares like there is no tomorrow. Get out now while the gettin is good!

Recs

0
Member Avatar notUSA (20.94) Submitted: 12/3/2010 2:52:11 PM : Outperform Start Price: $8.00 MITI Score: +28.47

#1 pick for cure in cancer

Recs

1
Member Avatar kidderpeabodyny (98.95) Submitted: 10/11/2010 10:54:09 AM : Outperform Start Price: $7.10 MITI Score: +38.67

see www.micromet.com for info....
explosive potential, also consider buy of AZA, Astra Zeneka who owns Medimmune which is partnering with Micromet.

Recs

0
Member Avatar FoolishJayhawk (79.37) Submitted: 8/6/2010 8:18:50 PM : Outperform Start Price: $6.70 MITI Score: +42.59

The BiTE antibody is ingenious and has lots of potential.

Recs

0
Member Avatar kblumbio (< 20) Submitted: 6/30/2010 1:02:17 PM : Outperform Start Price: $6.47 MITI Score: +40.58

Phase 1 Data on MT110 2nd Bite for solid tumors late this year early next!

Recs

0
Member Avatar Stageplayer (< 20) Submitted: 6/3/2010 11:24:06 AM : Outperform Start Price: $6.50 MITI Score: +46.80

This company may be on the verge of a possible cure for cancer.

Recs

0
Member Avatar NarGuy (63.68) Submitted: 7/19/2009 9:35:40 PM : Outperform Start Price: $4.93 MITI Score: +79.52

Innovative technology, using antibodies to make the immune system attack cancer cells could be a major breakthrough, plus they have had positive results in clinical trials

Recs

0
Member Avatar gdleon (< 20) Submitted: 7/14/2009 12:29:50 AM : Outperform Start Price: $4.97 MITI Score: +70.95

their patented safe antibody platform will change the standard in treatment of cancer. they are going to create a royality system of revenues sold throughout the pharma industry. in 10 years , heres another 10 bagger.
Dr. D

Recs

0
Member Avatar noescaper (21.77) Submitted: 6/1/2009 9:17:23 PM : Underperform Start Price: $4.31 MITI Score: -110.24

4.5 and above is strong resistance in the near term.

Recs

0
Member Avatar cashsage (29.64) Submitted: 5/11/2009 10:00:31 AM : Underperform Start Price: $3.84 MITI Score: -136.62

MITI has a too high valuation compared to its sales potential. It is also one of the most loss making companies.

Recs

0
Member Avatar minimidgy (98.00) Submitted: 4/23/2009 11:51:13 AM : Underperform Start Price: $3.56 MITI Score: -145.52

- Forecasted Earnings per Share of $-0.73 per share
- P/E of of -4.82
- Earnings Yield of -20.74 percent
- Growth to P/E Ratio of -0.20

Recs

0
Member Avatar LawfordCap (99.94) Submitted: 3/24/2009 10:18:25 AM : Underperform Start Price: $2.75 MITI Score: -231.12

bad company ready to go down

Recs

0
Member Avatar R3ALGOOD (< 20) Submitted: 10/13/2008 7:29:22 PM : Outperform Start Price: $4.69 MITI Score: +101.82

Listen carefully: This stock will be at $20 on or around December 6th-9th. These dates are the 50th ASH meeting where MITI will present phae II data from its drug MT203. If results are positive, the stock will soar. So far, results have been close to 100% positive. December will be the time of the catalyst. Get in before its too late. Good Luck

Recs

3
Member Avatar TheParadox (71.38) Submitted: 9/24/2008 2:26:20 AM : Underperform Start Price: $4.92 MITI Score: -106.87

The worst company on earth.

Recs

0
Member Avatar WOODYHAZE (< 20) Submitted: 8/28/2008 9:23:09 AM : Outperform Start Price: $6.20 MITI Score: +69.37

Hope I'm not too late on this one....

Results 1 - 20 of 25 : 1 2 Next »

Featured Broker Partners


Advertisement